Ashley Kaplowitz | executive |
Barry Greene | executive |
Chris Benecchi | executive |
Laura Gault | executive |
Kimi Iguchi | executive |
Anupam Rama | analyst |
Ritu Baral | analyst |
Laura Chico | analyst |
Paul Matteis | analyst |
Jay Olson | analyst |
Ami Fadia | analyst |
Brian Abrahams | analyst |
George Farmer | analyst |
Sumant Kulkarni | analyst |
Michael Quirk | executive |
Yatin Suneja | analyst |
Douglas Tsao | analyst |
Good morning, and welcome to Sage Therapeutics First Quarter 2024 Financial Results Conference Call. [Operator Instructions]. Please note that this call is being recorded. I would now like to introduce Ashley Kaplowitz, Vice President of Investor Relations and Capital Markets at Sage.
Good morning, and thank you for joining Sage Therapeutics' First Quarter 2024 Financial Results Conference Call.